Literature DB >> 22867919

[Pleomorphic xanthoastrocytoma with intraventricular extension and anaplastic transformation in an adult patient: Case report].

Ruben Rodríguez-Mena1, Vicente Joanes-Alepuz, Rosa Barbella-Aponte, Ana Pérez-Valles.   

Abstract

Pleomorphic xanthoastrocytoma (PXA) is a rare, low-grade astrocytic tumour that usually occurs in the superficial cerebral hemispheres of children and young adults. Although it has a relatively favourable prognosis, malignant progression of these tumours has been described. Therefore, we present an unusual case of a 54-year-old male with a right, multicystic, parietooccipital tumour extending through the ipsilateral ventricle. After surgical resection, histological examination revealed a lesion with pleomorphic cells, cytoplasmic lipidisation, intensely eosinophilic granular bodies, well-delimitated unique nuclei and focal, positive immunoreactivity for synaptophysin, glial fibrillary acidic protein (GFAP), S-100 protein, vimentin and CD56. Once other tumours, such as giant cell metastatic carcinoma or primary lesion like subependymal giant cell astrocytoma, were ruled out, a final diagnosis of XAP was established. After a follow-up period of 9 months, the patient suffered an extensive and local tumour relapse considered inoperable, with progressive neurological deterioration and radiological findings of malignant progression. The brain biopsy procedure revealed anaplastic changes, including necrosis foci, higher mitotic activity (5×10 high-power fields) and a 10% proliferation index measured by Ki67 labelling. The present case showed intraventricular extension and a more aggressive behaviour, both uncommon in these tumours (similar to anaplastic astrocytoma or glioblastoma multiforme), thus demanding an initial, optimal surgical treatment with close clinical and radiological follow-up, due to the high potential for malignant transformation of XAPs.
Copyright © 2011 Sociedad Española de Neurocirugía. Published by Elsevier España. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22867919     DOI: 10.1016/j.neucir.2011.08.003

Source DB:  PubMed          Journal:  Neurocirugia (Astur)        ISSN: 1130-1473            Impact factor:   0.553


  4 in total

1.  BRAF mutation and CDKN2A deletion define a clinically distinct subgroup of childhood secondary high-grade glioma.

Authors:  Matthew Mistry; Nataliya Zhukova; Daniele Merico; Patricia Rakopoulos; Rahul Krishnatry; Mary Shago; James Stavropoulos; Noa Alon; Jason D Pole; Peter N Ray; Vilma Navickiene; Joshua Mangerel; Marc Remke; Pawel Buczkowicz; Vijay Ramaswamy; Ana Guerreiro Stucklin; Martin Li; Edwin J Young; Cindy Zhang; Pedro Castelo-Branco; Doua Bakry; Suzanne Laughlin; Adam Shlien; Jennifer Chan; Keith L Ligon; James T Rutka; Peter B Dirks; Michael D Taylor; Mark Greenberg; David Malkin; Annie Huang; Eric Bouffet; Cynthia E Hawkins; Uri Tabori
Journal:  J Clin Oncol       Date:  2015-02-09       Impact factor: 44.544

Review 2.  [Independent innovation research, development and transformation of precise bionic repair technology for oral prosthesis].

Authors:  Y C Sun; Y Q Guo; H Chen; K H Deng; W W Li
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2022-02-18

3.  A rare clinical presentation: a pleomorphic xanthoastrocytoma presenting with intracerebral haemorrhage and metastasizing vigorously-case report and review of the literature.

Authors:  Gülden Demirci Otluoğlu; M Memet Özek
Journal:  Childs Nerv Syst       Date:  2018-09-04       Impact factor: 1.475

4.  DNA methylation alterations in grade II- and anaplastic pleomorphic xanthoastrocytoma.

Authors:  Ramón Martínez; F Javier Carmona; Miguel Vizoso; Veit Rohde; Matthias Kirsch; Gabriele Schackert; Santiago Ropero; Werner Paulus; Alonso Barrantes; Antonio Gomez; Manel Esteller
Journal:  BMC Cancer       Date:  2014-03-20       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.